ALG13-Congenital Disorder of Glycosylation (ALG13-CDG): Updated clinical and molecular review and clinical management guidelines.

MLA

Shah, Rameen, et al. “ALG13-Congenital Disorder of Glycosylation (ALG13-CDG): Updated Clinical and Molecular Review and Clinical Management Guidelines.” Molecular Genetics and Metabolism, vol. 142, no. 2, June 2024, p. 108472. EBSCOhost, https://doi.org/10.1016/j.ymgme.2024.108472.

APA

Shah, R., Eklund, E. A., Radenkovic, S., Sadek, M., Shammas, I., Verberkmoes, S., Ng, B. G., Freeze, H. H., Edmondson, A. C., He, M., Kozicz, T., Altassan, R., & Morava, E. (2024). ALG13-Congenital Disorder of Glycosylation (ALG13-CDG): Updated clinical and molecular review and clinical management guidelines. Molecular Genetics and Metabolism, 142(2), 108472. https://doi.org/10.1016/j.ymgme.2024.108472

Chicago

Shah, Rameen, Erik A Eklund, Silvia Radenkovic, Mustafa Sadek, Ibrahim Shammas, Sanne Verberkmoes, Bobby G Ng, et al. 2024. “ALG13-Congenital Disorder of Glycosylation (ALG13-CDG): Updated Clinical and Molecular Review and Clinical Management Guidelines.” Molecular Genetics and Metabolism 142 (2): 108472. doi:10.1016/j.ymgme.2024.108472.